In our study, 63% of patients with acute-phase disease expressed the p190 transcript (typical Ph+ ALL), while 37.0% expressed the p210 transcript, including seven cases with co-expression of two or three transcripts. The gene discussed is CNTNAP1; the disease is acute lymphoblastic leukemia.